7CHO
Crystal structure of SARS-CoV-2 antibody P5A-1D2 with RBD
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRF BEAMLINE BL17U |
Synchrotron site | SSRF |
Beamline | BL17U |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2020-05-17 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 0.9796 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 158.754, 67.509, 154.368 |
Unit cell angles | 90.00, 112.18, 90.00 |
Refinement procedure
Resolution | 36.523 - 2.561 |
R-factor | 0.204 |
Rwork | 0.202 |
R-free | 0.24730 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 6m0j |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX (1.15.2_3472) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 2.660 |
High resolution limit [Å] | 2.560 | 2.600 |
Rmerge | 0.117 | 0.799 |
Number of reflections | 47159 | 3117 |
<I/σ(I)> | 9.5 | |
Completeness [%] | 95.9 | |
Redundancy | 6.3 | |
CC(1/2) | 0.989 | 0.450 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 298 | 0.2M Magnesium chloride hexahydrate, 0.1M Tris, pH 8.5, 3.4M 1,6-Hexanediol |